Uscom Limited

ASX:UCM ISIN:AU000000UCM2

Uscom Limited is an Australian medical device company, listed on the Australian Stock Exchange since December 2003. Uscom has developed a device for the safe and accurate measurement of cardiac output, a non-invasive alternative to the current invasive methods. Uscom offers a completely safe, painless and quick method of accurately measuring how well the heart is pumping. With its real-time beat-to-beat information across multiple parameters of cardiac function and advanced serial measurement capabilities, clinicians can accurately quantify the impact of therapy. The device is ideally suited to the Emergency Care setting where it is critical to monitor changes in cardiac output as fluids are applied. 
 
 

查看其它语言版本

新闻

澳Uscom(ASX:UCM)无创心血管监测仪获中国ICU学会认可

🕔5/27/2015 10942

ACB News《澳华财经在线》报道,据悉共有4种监测方法纳入ICU学会调查范围,只有USCOM 1A专注于无创心血管监测技术,其余3种均基于侵入性导管量测技术。

阅读全文
###

11,634 公司背景浏览

  • 本页浏览人次: (过去7日: 19) (过去30日: 68) (自发布以来: 6329) 

公司详细信息

    电话
  • 02 9247 4144 
  • 传真
  • (02) 9247 8157 
  • 主要部门
  • 医疗-制药 
  • 支柱产业
  • 保健 
  • 主页
  • www.uscom.com.au

更多新闻纪录

  • 2024/10/31: Quarterly Activities/Appendix 4C Cash Flow Report*
  • 2024/10/29: Change of Director's Interest Notice - Phillips*
  • 2024/10/25: Notification regarding unquoted securities - UCM*
  • 2024/10/25: Results of 2024 AGM*
  • 2024/10/25: FY24 AGM Presentation and Update*
  • 2024/09/30: Notice of Annual General Meeting/Proxy Form*
  • 2024/09/24: Notice of Annual General Meeting/Proxy Form*
  • 2024/09/24: Letter to shareholders re AGM*
  • 2024/09/04: Cleansing notice*
  • 2024/09/04: Application for quotation of securities - UCM*
*refer to company website